Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)
about
Biosimilars in rheumatology: understanding the rigor of their developmentPsoriasis registries worldwide: systematic overview on registry publications.The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countriesCurrent status and future prospects for biologic treatments of psoriasis.Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis.Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).Primary care-based screening for cardiovascular risk factors in patients with psoriasis.Review of U.S. Registries for Psoriasis.Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients.Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.Therapeutic insights from the British Association of Dermatologists Biologic Interventions Register.Epidemiology of mental health comorbidity in psoriasis.Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions - A Cross-Sectional Study.Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib.Treatment history of patients receiving biologic therapy for psoriasis - a Danish nationwide study.Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
P2860
Q26744773-B05C112A-DC12-4007-A6F7-E34C352F2D95Q30251454-27D2C848-AB88-4A4E-8C2D-696C916AB885Q35228919-AF4C6AE4-E4F7-44C6-9604-3B19AC39F1E5Q36057909-713E2BAD-A129-4241-B49A-4F28D34F7510Q36083240-B83221AB-EFA0-418D-A709-10AEC5B9168EQ36466692-7E65F3C2-FC7A-4F5E-89D5-D93F759D3ABBQ36942993-7A809006-AC3C-4B61-8130-F2F854CB6F74Q37098500-14834633-69DC-44D6-BAFC-9C63CC1698C6Q37352347-C5A895DC-AC21-423A-9A85-19F98F2310A5Q37420435-453F32C8-1EC3-4C01-BEA6-32EC2984E104Q38798326-A7896853-F746-45B2-BA40-578EFAE271BBQ39004998-B53E34DB-2697-492E-9DA3-D6753A13F4D7Q40129865-300F102D-455C-452D-AC3E-A86289E20CB9Q40380596-C6B088B9-9F03-44CA-90F0-A2FCC8178C05Q41395652-A83D3D76-25D3-42EF-BAED-49C7CC765311Q45983342-C2E699AF-EA50-484D-96E0-3A3BB6776247Q47347206-EF9DEFB3-21C2-42D0-8504-5756D5EAF4B2Q50124668-93834C1B-ED6C-42F7-88F6-7E2BE570F35DQ50574499-1D13473B-F932-4C3A-AD19-F8E4E00B9D4FQ53828883-1EC65534-4D1B-4E48-BC20-27D6F4C3F0C5
P2860
Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@ast
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@en
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@nl
type
label
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@ast
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@en
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@nl
prefLabel
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@ast
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@en
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@nl
P2093
P2860
P356
P1476
Demography, baseline disease c ...... isease-based registry (PSOLAR)
@en
P2093
A B Kimball
C Leonardi
M Chevrier
PSOLAR Steering Committee
S Fakharzadeh
W Gulliver
P2860
P304
P356
10.1111/BJD.13013
P407
P577
2014-07-16T00:00:00Z